E2 ModeratePreliminaryPEM unclearCross-SectionalPeer-reviewedMachine draft
Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome.
Gaab, Jens, Engert, Veronika, Heitz, Vera et al. · Journal of psychosomatic research · 2004 · DOI
Quick Summary
This study tested whether ME/CFS patients have problems with their stress hormone system (the HPA axis). Researchers gave 18 ME/CFS patients and 17 healthy controls a special test that triggers the body's stress response and measured their hormones. They found that ME/CFS patients had a weaker hormone response, and this weakness was linked to how long someone had been sick and how severe their fatigue was.
Why It Matters
This research provides objective neuroendocrine evidence of HPA axis dysfunction in ME/CFS and suggests that the severity of this dysfunction may reflect disease progression. Understanding whether hormonal dysregulation is a primary cause or a consequence of prolonged illness is critical for developing targeted treatments and may explain some of ME/CFS's core symptoms.
Observed Findings
- ME/CFS patients had significantly reduced ACTH response to the insulin tolerance test compared to healthy controls.
- ACTH response was strongly negatively correlated with duration of CFS symptoms (r = -0.592, P = 0.005).
- ACTH response was moderately negatively correlated with fatigue severity (r = -0.41, P = 0.045).
- Duration of CFS symptoms was positively correlated with fatigue severity (r = 0.38, P = 0.045).
- Cortisol parameters did not show significant associations with patient characteristics.
Inferred Conclusions
- HPA axis dysregulation in ME/CFS appears to be acquired rather than primary, potentially developing as a consequence of prolonged illness.
- Factors associated with disease chronicity, such as profound inactivity, deconditioning, and sleep abnormalities, may be candidates for secondary causes of neuroendocrine dysregulation in ME/CFS.
- The strength of association between ACTH response and symptom duration suggests that neuroendocrine changes may reflect disease progression rather than serve as a primary causative mechanism.
Remaining Questions
- Is HPA axis dysregulation a cause or a consequence of ME/CFS, and can it be reversed with appropriate treatment?
- What specific factors—inactivity, deconditioning, sleep disturbance—most directly drive the observed ACTH dysregulation?
What This Study Does Not Prove
This study does not prove that HPA axis dysregulation causes ME/CFS or that correcting it will treat the disease. The cross-sectional design cannot establish causation or determine whether the hormonal changes preceded or resulted from prolonged illness. The small sample size (n=18) limits generalizability, and the findings do not explain whether other physiological systems are also involved in ME/CFS pathophysiology.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Method Flag:PEM Not DefinedWeak Case DefinitionSmall SampleExploratory Only
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →